KOMAL KUMAR

Employment

• Lund University Department of Biochemistry and Structural Biology Postdoctoral Fellow
  2013 - 2015

Education

• University of Linkoping PhD
  2013 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine
  The Journal of experimental medicine 2022 DOI: 10.1084/jem.20212228
  +Save
• Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets
  Leukemia 2021 DOI: 10.1038/s41375-020-01082-4
  +Save
• Patient-tailored design for selective co-inhibition of leukemic cell subpopulations
  Science Advances 2021 DOI: 10.1126/sciadv.abe4038
  +Save
• KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia
  Leukemia 2020 DOI: 10.1038/s41375-020-0978-7
  +Save
• Patient-tailored design of AML cell subpopulation-selective drug combinations
  bioRxiv 2020 DOI: 10.1101/2020.07.28.222034
  +Save
• Dasatinib and navitoclax act synergistically to target NUP98-NSD1 +/FLT3-ITD+ acute myeloid leukemia
  Leukemia 2019 DOI: 10.1038/s41375-018-0327-2
  +Save
• A Multiplexed Screening Assay to Evaluate Chemotherapy-Induced Myelosuppression Using Healthy Peripheral Blood and Bone Marrow
  SLAS Discovery 2018 DOI: 10.1177/2472555218777968
  +Save
• JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML
  Blood 2017 DOI: 10.1182/blood-2016-02-699363
  +Save
• Bioactivity of diterpens from the ethyl acetate extract of Kingiodendron pinnatum rox. hams
  Pharmacognosy Research 2016 DOI: 10.4103/0974-8490.188871
  +Save
• Leukeima
  Experimental Hematology 2015
  +Save